ICU Medical, Inc. (NASDAQ:ICUI – Get Rating) shares reached a new 52-week low on Tuesday . The stock traded as low as $154.81 and last traded at $154.81, with a volume of 164 shares changing hands. The stock had previously closed at $157.38.
Analyst Ratings Changes
A number of equities analysts have weighed in on the stock. Raymond James cut their target price on shares of ICU Medical from $208.00 to $190.00 and set an "outperform" rating for the company in a research report on Tuesday, August 9th. KeyCorp reduced their price target on ICU Medical from $230.00 to $225.00 in a report on Tuesday, August 9th. StockNews.com raised ICU Medical from a "sell" rating to a "hold" rating in a research report on Monday. Finally, TheStreet lowered ICU Medical from a "b-" rating to a "c" rating in a research report on Wednesday, May 11th.
Get ICU Medical alerts:ICU Medical Trading Up 5.9 %
The company has a 50-day moving average of $168.41 and a 200 day moving average of $192.15. The company has a market cap of $3.95 billion, a PE ratio of 393.58 and a beta of 0.57. The company has a debt-to-equity ratio of 0.78, a current ratio of 2.45 and a quick ratio of 1.25.
ICU Medical (NASDAQ:ICUI – Get Rating) last issued its quarterly earnings data on Monday, August 8th. The medical instruments supplier reported $1.37 EPS for the quarter, missing analysts' consensus estimates of $1.68 by ($0.31). ICU Medical had a return on equity of 6.97% and a net margin of 0.31%. The business had revenue of $561.00 million during the quarter, compared to the consensus estimate of $569.30 million. During the same period last year, the firm earned $1.57 EPS. The business's quarterly revenue was up 74.4% on a year-over-year basis. Analysts predict that ICU Medical, Inc. will post 5.23 earnings per share for the current year.Institutional Trading of ICU Medical
Several hedge funds have recently made changes to their positions in ICUI. Advisor Group Holdings Inc. raised its holdings in shares of ICU Medical by 7.5% in the 4th quarter. Advisor Group Holdings Inc. now owns 847 shares of the medical instruments supplier's stock valued at $202,000 after purchasing an additional 59 shares in the last quarter. American Century Companies Inc. boosted its holdings in shares of ICU Medical by 18.8% in the fourth quarter. American Century Companies Inc. now owns 3,792 shares of the medical instruments supplier's stock valued at $900,000 after acquiring an additional 600 shares in the last quarter. ProShare Advisors LLC boosted its holdings in ICU Medical by 24.4% during the fourth quarter. ProShare Advisors LLC now owns 2,302 shares of the medical instruments supplier's stock worth $546,000 after buying an additional 452 shares in the last quarter. Dimensional Fund Advisors LP raised its position in ICU Medical by 1.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 335,891 shares of the medical instruments supplier's stock worth $79,722,000 after acquiring an additional 4,107 shares during the last quarter. Finally, AlphaCrest Capital Management LLC raised its position in ICU Medical by 281.2% during the fourth quarter. AlphaCrest Capital Management LLC now owns 5,695 shares of the medical instruments supplier's stock worth $1,352,000 after acquiring an additional 4,201 shares during the last quarter. Hedge funds and other institutional investors own 90.20% of the company's stock.
ICU Medical Company Profile
(Get Rating)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.
Further Reading
- Get a free copy of the StockNews.com research report on ICU Medical (ICUI)
- 3 High Margin Chipmakers Bound to Recover
- 3 Solar Stocks That Will Benefit From the Biden Tariff Holiday
- REV Group Has A Deep Moat In The World Of EVs
- Is G-III Apparel Group, Ltd. A Value Trap?
- Bank Of America Sees Upside In These 2 European Alcohol Stocks
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.